Abeona Therapeutics (ABEO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.43, -4.73% vs the prior close of $4.65.
- Volume 819.50K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ABEO slides 4.7% to $4.43. Closed at $4.43, -4.73% vs the prior close of $4.65. Day range $4.39–$4.66, opened at $4.66.
ABEO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ABEO slides 4.7% to $4.43
- Closed at $4.43, -4.73% vs the prior close of $4.65. Day range $4.39–$4.66, opened at $4.66.
- Volume was 819.50K shares, 0.5x its 50-day average of 1.50M — lighter than usual.
- Price is -21.9% vs its 50-day average ($5.67) and -19.9% vs its 200-day average ($5.53).
- 52-week range $4.00–$7.65; today's close sits at 12% of that range, 42.1% below the 52-week high.
Oct 15, 2026 — ABEO jumps 6.7% to $4.65
- Closed at $4.65, +6.65% vs the prior close of $4.36. Day range $4.35–$4.79, opened at $4.39.
- Volume was 1.38M shares, 0.9x its 50-day average of 1.48M.
- Price is -18.7% vs its 50-day average ($5.72) and -16.0% vs its 200-day average ($5.53).
- 52-week range $4.00–$7.65; today's close sits at 18% of that range, 39.2% below the 52-week high.
Oct 14, 2026 — ABEO slides 3.5% to $4.36, a 6-month low, 5 down days in a row
- Closed at $4.36, -3.54% vs the prior close of $4.52. Day range $4.28–$4.51, opened at $4.48.
- Volume was 1.77M shares, 1.2x its 50-day average of 1.47M.
- Price is -24.4% vs its 50-day average ($5.77) and -21.3% vs its 200-day average ($5.54).
- 52-week range $4.00–$7.65; today's close sits at 10% of that range, 43.0% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — ABEO slides 7.8% to $4.52, a 6-month low, 4 down days in a row
- Closed at $4.52, -7.76% vs the prior close of $4.90. Day range $4.51–$4.88, opened at $4.88.
- Volume was 1.98M shares, 1.4x its 50-day average of 1.45M.
- Price is -22.3% vs its 50-day average ($5.81) and -18.4% vs its 200-day average ($5.54).
- 52-week range $4.00–$7.65; today's close sits at 14% of that range, 40.9% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — ABEO dips 0.8% to $4.90, a 6-month low, 3 down days in a row
- Closed at $4.90, -0.81% vs the prior close of $4.94. Day range $4.86–$4.95, opened at $4.93.
- Volume was 758.00K shares, 0.5x its 50-day average of 1.45M — lighter than usual.
- Price is -16.3% vs its 50-day average ($5.85) and -11.7% vs its 200-day average ($5.55).
- 52-week range $4.00–$7.65; today's close sits at 25% of that range, 35.9% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — ABEO dips 0.4% to $4.94, a 3-month low
- Closed at $4.94, -0.40% vs the prior close of $4.96. Day range $4.89–$5.04, opened at $4.94.
- Volume was 1.28M shares, 0.9x its 50-day average of 1.44M.
- Price is -16.0% vs its 50-day average ($5.88) and -11.0% vs its 200-day average ($5.55).
- 52-week range $4.00–$7.65; today's close sits at 26% of that range, 35.4% below the 52-week high.
Oct 8, 2026 — ABEO dips 2.4% to $4.96, a 3-month low
- Closed at $4.96, -2.36% vs the prior close of $5.08. Day range $4.94–$5.05, opened at $5.04.
- Volume was 1.63M shares, 1.1x its 50-day average of 1.44M.
- Price is -16.1% vs its 50-day average ($5.91) and -10.6% vs its 200-day average ($5.55).
- 52-week range $4.00–$7.65; today's close sits at 26% of that range, 35.2% below the 52-week high.
Oct 7, 2026 — ABEO rises 1.4% to $5.08
- Closed at $5.08, +1.40% vs the prior close of $5.01. Day range $4.93–$5.10, opened at $4.95.
- Volume was 737.70K shares, 0.5x its 50-day average of 1.45M — lighter than usual.
- Price is -14.5% vs its 50-day average ($5.94) and -8.5% vs its 200-day average ($5.55).
- 52-week range $4.00–$7.65; today's close sits at 30% of that range, 33.6% below the 52-week high.
Oct 6, 2026 — ABEO dips 2.0% to $5.01
- Closed at $5.01, -1.96% vs the prior close of $5.11. Day range $4.89–$5.16, opened at $5.16.
- Volume was 1.42M shares, 1.0x its 50-day average of 1.43M.
- Price is -15.9% vs its 50-day average ($5.96) and -9.7% vs its 200-day average ($5.55).
- 52-week range $4.00–$7.65; today's close sits at 28% of that range, 34.5% below the 52-week high.
Oct 5, 2026 — ABEO rises 1.6% to $5.11
- Closed at $5.11, +1.59% vs the prior close of $5.03. Day range $4.99–$5.16, opened at $5.07.
- Volume was 1.40M shares, 1.0x its 50-day average of 1.43M.
- Price is -14.5% vs its 50-day average ($5.98) and -7.9% vs its 200-day average ($5.55).
- 52-week range $4.00–$7.65; today's close sits at 30% of that range, 33.2% below the 52-week high.
Oct 2, 2026 — ABEO rises 0.4% to $5.03
- Closed at $5.03, +0.40% vs the prior close of $5.01. Day range $4.99–$5.11, opened at $5.09.
- Volume was 1.21M shares, 0.9x its 50-day average of 1.42M.
- Price is -16.1% vs its 50-day average ($6.00) and -9.4% vs its 200-day average ($5.55).
- 52-week range $4.00–$7.65; today's close sits at 28% of that range, 34.2% below the 52-week high.
ABEO latest news & SEC filings
Every SEC filing by or about ABEO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Seshadri Vishwas sold 19,608 shares at $5.16 (≈$101.09K) on Sep 29, 2026; now holds 1,286,500
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vazzano Joseph Walter sold 9,191 shares at $5.16 (≈$47.39K) on Sep 29, 2026; now holds 482,888
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- O'Malley Brendan M. sold 6,727 shares at $5.16 (≈$34.68K) on Sep 29, 2026; now holds 421,226
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Vasanthavada Madhav sold 4,902 shares at $5.16 (≈$25.27K) on Sep 29, 2026; now holds 285,721
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 29, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $11.38M (prior year $400.00K) (+2745.0% vs Jun 30, 2025)
- Net income: -$20.19M (prior year $108.83M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.35 (prior year $1.71) (loss widened vs Jun 30, 2025)
Aug 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 10, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jun 26, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Things to know before you trade ABEO
- Last results release: Aug 13, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 17, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Nov 12, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.71% (largest 7.8%).
- Liquidity: about 1.20M shares (≈$5.30M) trade per day on average.
- 52-week position: $4.43 vs a range of $4.00–$7.65 (12% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Vishwas Seshadri sold 19,608 shares on Sep 29, 2026.
- Latest filings: 8-K Sep 15, 2026; 10-Q Aug 13, 2026; 8-K Aug 13, 2026.
- Share count: 57.18M shares outstanding (Aug 10, 2026), +11.5% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ABEO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.66 | 4.66 | 4.39 | 4.43 | 819.50K |
| Oct 15, 2026 | 4.39 | 4.79 | 4.35 | 4.65 | 1.38M |
| Oct 14, 2026 | 4.48 | 4.51 | 4.28 | 4.36 | 1.77M |
| Oct 13, 2026 | 4.88 | 4.88 | 4.51 | 4.52 | 1.98M |
| Oct 12, 2026 | 4.93 | 4.95 | 4.86 | 4.90 | 758.00K |
| Oct 9, 2026 | 4.94 | 5.04 | 4.89 | 4.94 | 1.28M |
| Oct 8, 2026 | 5.04 | 5.05 | 4.94 | 4.96 | 1.63M |
| Oct 7, 2026 | 4.95 | 5.10 | 4.93 | 5.08 | 737.70K |
| Oct 6, 2026 | 5.16 | 5.16 | 4.89 | 5.01 | 1.42M |
| Oct 5, 2026 | 5.07 | 5.16 | 4.99 | 5.11 | 1.40M |
| Oct 2, 2026 | 5.09 | 5.11 | 4.99 | 5.03 | 1.21M |
| Oct 1, 2026 | 5.22 | 5.25 | 4.99 | 5.01 | 1.48M |
| Sep 30, 2026 | 5.16 | 5.33 | 5.10 | 5.25 | 1.13M |
| Sep 29, 2026 | 5.30 | 5.30 | 5.11 | 5.16 | 1.25M |
| Sep 28, 2026 | 5.35 | 5.40 | 5.19 | 5.29 | 872.90K |
| Sep 25, 2026 | 5.45 | 5.48 | 5.34 | 5.40 | 720.70K |
| Sep 24, 2026 | 5.59 | 5.59 | 5.38 | 5.43 | 852.40K |
| Sep 23, 2026 | 5.82 | 5.90 | 5.52 | 5.53 | 1.19M |
| Sep 22, 2026 | 5.71 | 5.87 | 5.69 | 5.82 | 1.02M |
| Sep 21, 2026 | 5.66 | 5.68 | 5.59 | 5.67 | 1.01M |
About Abeona Therapeutics
Abeona Therapeutics (ABEO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CLEVELAND, OH. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 318306.
ABEO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Leila Alland | Director | Jul 2, 2026 |
| Mark Alvino | Director | Sep 1, 2026 |
| Michael Amoroso | Director | Jan 27, 2026 |
| Faith L. Charles | Director | Jan 27, 2026 |
| Eric Crombez | Director | May 15, 2026 |
| Keith A. Goldan | Director | Apr 7, 2026 |
| Vishwas Seshadri | Chief Executive Officer | Sep 29, 2026 |
| Christine Berni Silverstein | Director | Jun 15, 2026 |
| Donald A. Wuchterl | Director | Feb 2, 2026 |
| Bernhardt G Zeiher | Director | Jan 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Brendan M. O'Malley | SVP, Chief Legal Officer | Sep 29, 2026 |
| Vishwas Seshadri | Chief Executive Officer | Sep 29, 2026 |
| Madhav Vasanthavada | Chief Commercial Officer | Sep 29, 2026 |
| Joseph Walter Vazzano | Chief Financial Officer | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 29, 2026 | Vishwas Seshadri | Sale | 19,608 | $5.16 |
| Sep 29, 2026 | Vishwas Seshadri | Sale | 19,608 | $5.16 |
| Sep 29, 2026 | Vishwas Seshadri | Sale | 19,608 | $5.16 |
| Sep 29, 2026 | Vishwas Seshadri | Sale | 19,608 | $5.16 |
| Sep 29, 2026 | Madhav Vasanthavada | Sale | 4,902 | $5.16 |
| Sep 29, 2026 | Madhav Vasanthavada | Sale | 4,902 | $5.16 |
| Sep 29, 2026 | Madhav Vasanthavada | Sale | 4,902 | $5.16 |
| Sep 29, 2026 | Madhav Vasanthavada | Sale | 4,902 | $5.16 |
| Sep 29, 2026 | Brendan M. O'Malley | Sale | 6,727 | $5.16 |
| Sep 29, 2026 | Brendan M. O'Malley | Sale | 6,727 | $5.16 |
| Sep 29, 2026 | Brendan M. O'Malley | Sale | 6,727 | $5.16 |
| Sep 29, 2026 | Brendan M. O'Malley | Sale | 6,727 | $5.16 |
| Sep 29, 2026 | Joseph Walter Vazzano | Sale | 9,191 | $5.16 |
| Sep 29, 2026 | Joseph Walter Vazzano | Sale | 9,191 | $5.16 |
| Sep 29, 2026 | Joseph Walter Vazzano | Sale | 9,191 | $5.16 |
ABEO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $5.82M | $71.18M | 1.01 | $-76.33M |
| Dec 31, 2024 | — | $-63.73M | -1.55 | $-56.02M |
| Dec 31, 2023 | $3.50M | $-54.19M | -2.53 | $-37.01M |
| Dec 31, 2022 | $1.41M | $-39.70M | -5.53 | $-43.48M |
| Dec 31, 2021 | $3.00M | $-84.94M | — | $-65.67M |
Latest balance sheet: total assets $179.51M, total liabilities $51.45M, cash $56.23M (as of Jun 30, 2026).
ABEO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 13, 2026 | 8-K Item 2.02 (results) | $6.35 |
| May 13, 2026 | 8-K Item 2.02 (results) | $5.71 |
| Mar 17, 2026 | 8-K Item 2.02 (results) | $4.76 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $4.94 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $7.23 |
| Jul 2, 2025 | 8-K Item 2.02 (results) | $5.87 |
| May 15, 2025 | 8-K Item 2.02 (results) | $5.79 |
| Mar 20, 2025 | 8-K Item 2.02 (results) | $5.14 |
| Nov 14, 2024 | 8-K Item 2.02 (results) | $5.95 |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
| May 15, 2024 | 8-K Item 2.02 (results) | — |
| May 3, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ABEO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.